Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Improving Cerebral Blood Flow and Cognition in Patients with Cerebral Small Vessel Disease. the ETLAS-2 Trial

NCT05173896 is registered in ClinicalTrials.gov with Christina Kruuse as lead sponsor.

NCT NCT05173896
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05173896 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Improving Cerebral Blood Flow and Cognition in Patients with Cerebral Small Vessel Disease. the ETLAS-2 Trial
Lead sponsor
Christina Kruuse
Phase
Phase 2
Overall status
Active, not recruiting
Start date
May 31, 2022
Completion date
December 31, 2029
Enrollment
100 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral small vessel diseases, stroke, ischemic